期刊文献+

急性心力衰竭入院时收缩压水平与心功能及预后关系 被引量:6

Relationship among cardiac function,prognosis and level of systolic blood pressure at admission in patients with acute heart failure
下载PDF
导出
摘要 目的:探讨急性心力衰竭患者入院时收缩压(SBP)水平与心功能及预后的关系。方法:研究对象为急性心力衰竭住院的患者229例,按入院时SBP水平分为:A组(SBP≤100mmHg,22例),B组(100mmHg<SBP≤140mmHg,123例),C组(SBP>140mmHg,84例),测定入院后N末端B型利钠肽前体(NT-proBNP)、肌酐等水平,并测量心胸比例、左室舒张末容积(LVEDV)、左室射血分数(LVEF)等。半年后根据有无心源性死亡分为事件组(65例)和非事件组(164例)。结果:不同血压组间lgNT-proBNP、LVEF、LVEDV均有显著性差异(P均<0.01);Pearson相关分析显示,SBP水平与lgNT-proBNP、心胸比、LVEDV呈负相关(r分别为-0.382,-0.546,-0.401,P均<0.01),与LVEF呈正相关(r=0.678,P<0.01)。与非事件组比较,事件组的心功能NYHAⅣ级比例(42.1%比70.8%)、心胸比[(0.55±0.07)比(0.60±0.07)]、LVEDV[(87.85±36.93)ml比(119.74±70.38)ml]明显增加,lgNT-proBNP[(3.58±0.37)pg/ml比(4.05±0.32)pg/ml]水平明显升高(P均<0.05);而其肌酐清除率[(57.81±24.98)ml/min比(49.40±28.32)ml/min],LVEF[(51.51±8.95)%比(42.45±8.41)%],SBP[(141.19±27.80)mmHg比(120.30±21.03)mmHg]水平则显著降低(P均<0.05)。A组患者心源性死亡事件发生率明显高于B、C组患者(54.6%比34.2%比13.1%,P<0.01)。结论:入院收缩压水平是反映急性心力衰竭患者心功能的一项重要指标。收缩压水平越低,预后越差。 Objective: To study relationship among cardiac function, prognosis and different level of systolic blood pressure (SBP) at admission in patients with acute heart failure (AHF). Methods: A total of 229 AHF inpatients were enrolled and their cardiac function was assessed by NYHA classification. According to SBP level at admission, 229 patients were divided into group A (SBP≤100mmHg, n = 22), group B (100mmHg〈SBP≤140mmHg, n = 123) and group C (SBP〉 140mmHg, n = 84). Levels of N terminal pro brain natriuretic peptide (NT-proBNP), creatinine, cardiothoracic ratio (C/T), left ventricular end-diastolic volume (LVEDV) and left ventricular ejection fraction (LVEF) were measured after admission. According to cardiogenic death or not after six-month follow-up, patients were divided into event group (n = 65) and no event group (n = 164). Results: There were significant difference in lgNT-proBNP, LVEF and LVEDV among three groups (P〈0. 01 all); Pearson correlation analysis indicated that SBP level was negatively correlated with lgNT-proBNP, C/T and LVEDV (r = -0. 382, -0. 546, - 0. 401 respectively, P〈0.01 all), and positively correlated with LVEF (r = 0. 678, P〈0.01). Compared with no event group, there were significant increase in percentage of patients with NYHA cardiac function classⅣ (42.1% vs. 70.8%), C/T[ (0.55±0.07) vs. (0.60±0.07)], LVEDV [ (87.85±36.93) mlvs. (119.74±70.38) ml], lgNT-proBNP [ (3.58 ± 0.37) pg/ml vs. (4.05 ± 0.32) pg/ml], P〈0.05 all; and significant decrease in creatinineclearance rate [ (57. 81 ± 24.98) ml/min vs. (49.40 ± 28.32) ml/min], levels of LVEF [ (51.51 ± 8. 95)% vs. (42.45 ± 8.41) %] and SBP [ (141.19 ± 27.80) mmHg vs. (120.30 ± 21.03) mmHg] in event group, P〈0.05 all. Incidence rate of cardiogenic death in group A was significantly higher than those of group B and C (54.5% vs. 34.1% vs. 13.1%, P〈0.01). Conclusion.. Level of systolic blood pressure at admission is an important index re- flecting cardiac function in patients with acute heart failure.
出处 《心血管康复医学杂志》 CAS 2013年第1期33-36,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 心力衰竭 血压 心室功能 利钠肽 Heart failures Blood pressures Ventricular functions Natriuretic peptide, brain
  • 相关文献

参考文献10

  • 1Femandez AA,Ferrante D,Hrabar A. Prognosis and clinical characteristics of levels of BMI in the heart failure[J].Poster Dislay Ⅳ Prognosis,2005.155-156.
  • 2Ozcan C,Jahangir A,Friedman PA. Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and long-term survival in patients with atrial fibrillation and left ventricular dysfunction[J].American Journal of Cardiology,2003,(01):33-37.
  • 3顾东风,黄广勇,吴锡桂,段秀芳,何江,Paul K Whelton,Stephen Mac Mahon.中国心力衰竭流行病学调查及其患病率[J].中华心血管病杂志,2003,31(1):3-6. 被引量:1277
  • 4Thohan V. Prognostic implications of echocardiography in advanced heart failure[J].Current Opinion in Cardiology,2004,(03):238-249.doi:10.1097/00001573-200405000-00009.
  • 5Guzzetti S,La Rovere MT,Pinna GD. Different spectral components of 24h heart rate variability are related to different modes of death in chronic heart failure[J].European Heart Journal,2005,(04):357-362.
  • 6Gheorghiade M,Abraham WT,Albert NM. Syatolic blood pressure at admission,clinical characteristics and outcomes in patients hospitalized with acute heart failure[J].Journal of the American Medical Association,2006,(18):2217-2226.
  • 7Solang L,Malmberg K,Ryden L. Diabetes mellitus and congestive heart failure.Further knowledge needed[J].European Heart Journal,1999,(11):789-795.
  • 8陈宏毅,陈慧,骆杰伟,吴小盈,伍严安,沈晓丽.高血压病并心力衰竭与ACE基因、SLC6A2基因多态性的关联研究[J].心血管康复医学杂志,2011,20(1):1-5. 被引量:9
  • 9Pfeffer MA. Blood pressure in heart failure:a love-hate relationship[J].Journal of the American College of Cardiology,2007,(01):40-42.
  • 10Gheorghiade M,Zannad F,Sopko G. Acute heart failure syndromes:current state and framework for future research[J].Circulation,2005,(25):3958-3968.

二级参考文献10

  • 1梅啸,彭健.肾素—血管紧张素系统基因多态性与慢性心力衰竭关系的研究进展[J].中国心血管病研究,2005,3(1):76-79. 被引量:14
  • 2刘旭东,李锦毅,史晶,李贺.去甲肾上腺素转运蛋白的研究进展[J].武警医学,2005,16(4):294-296. 被引量:9
  • 3Rigat B,Hubert C,Corvol P,et al.PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1)[J].Nucleic Acids Res,1992,20(6):1433.
  • 4Duncan JA,Scholey JW,Miller JA.Angiotensin Ⅱtype 1 receptor gene polymorphisms in humans:physiology and pathophysiology of the genotypes[J].Curr Opin Nephrol Hypertens,2001,10:111-116.
  • 5Schut AF,Bleumink GS,Stricher BH,et al.Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects[J].Eur Heart J,2004,25(23):2143-2148.
  • 6Cuoco MA,Pereara AC,de Freitas HF,et al.Angiotensin -converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure[J].Int J Cardiol,2005,99(1):97-103.
  • 7Serneri GGN,Biddi M,Cecioni I,et al.Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function[J].Circ Res,2001,88(9):961-968.
  • 8Niu TH,Chen X,Xu XP.Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease[J].Drugs,2002,62(7):977-993.
  • 9Schlaich MP,Lambert E,Kaye DM,et al.Sympathetic augmentation in hypertension:role of nerve firing,norepinephrine reuptake,and angiotensin neuromodulation[J].Hypertension,2004,43(2):169-175.
  • 10叶任高 主编.内科学:第5版[M].北京:人民卫生出版社,2001.824.

共引文献1283

同被引文献57

  • 1中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会,杨杰孚,张健,韩雅玲.中国心力衰竭诊断和治疗指南2018[J].中华心力衰竭和心肌病杂志(中英文),2018,2(4):196-225. 被引量:831
  • 2P e rez-Calvo JI, Montero-P e rez-Barquero M, Camafort-Babkowski M,et al. Influence of admission blood pressure on mortality in patients with acute decompensated heart failure [J]. QJM, 2011,104(4) :325-333.
  • 3Bernheim SM,Grady JN,Lin Z,et al. National patterns of risk- standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release [J]. Circ Cardiovasc Qual Outcomes, 2010,3 ( 5 ) : 459-467.
  • 4Gheorghiade M, Braunwald E. Hospitalizations for heart failure in the United States--a sign of hope [J]. JAMA,2011,306 (15): 1705-1706.
  • 5Fonarow G C,Stough W G,Abraham W T,et al.Characteristics,treatments,and outcomes of patients with preserved systolic function hospitalized for heart failure:a report from the OPTIMIZE-HF Registry[J].J Am Coll Cardiol,2007,50:768-777.
  • 6Owan T E,Redfield M M.Epidemiology of diastolic heart failure[J].Prog Cardiovasc Dis,2005,47:320-332.
  • 7Lam C,Donal E,Kraigher-krainer E,et al.Epidemiology and clinical course of heart failure with preserved ejection fraction[J].Eur J Heart Fail,2011,13:18-28.
  • 8Januzzi J L,Camargo C A,Anwaruddin S,et al.The N-terminal Pro-BNP investigation of dyspnea in the emergency department(PRIDE)studies[J].Am J Cardiol,2005,95:948-954.
  • 9Januzzi J L,van Kimmenade R,Lainchbury J,et al.NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure:an international pooled analysis of 1256patients.The International Collaborative of NT-proBNP Study[J].Eur Heart J,2006,27:330-337.
  • 10Golcuk Y,Golcuk B,Velibey Y,et al.Predictive cutoff point of admission N-terminal pro-B-type natriuretic peptide testing in the ED for prognosis of patients with acute heart failure[J].Am J Emerg Med,2013,31:1191-1195.

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部